| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.83B | 139.84B | 134.51B | 129.41B | 114.96B | 85.51B |
| Gross Profit | 31.75B | 34.01B | 31.07B | 29.53B | 25.05B | 18.23B |
| EBITDA | 2.51B | 2.54B | 2.32B | 3.69B | 1.22B | -2.13B |
| Net Income | 586.00M | 1.18B | 536.00M | 1.59B | 609.00M | -2.81B |
Balance Sheet | ||||||
| Total Assets | 36.86B | 38.37B | 36.06B | 33.95B | 33.09B | 28.54B |
| Cash, Cash Equivalents and Short-Term Investments | 3.42B | 2.94B | 2.84B | 3.17B | 2.75B | 2.75B |
| Total Debt | 9.44B | 10.25B | 9.19B | 8.62B | 10.47B | 11.76B |
| Total Liabilities | 32.59B | 33.36B | 31.83B | 29.84B | 30.27B | 26.23B |
| Stockholders Equity | 4.27B | 5.00B | 4.23B | 4.12B | 2.81B | 2.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 278.00M | 54.00M | 1.58B | 1.36B | -3.61B |
| Operating Cash Flow | 0.00 | 2.60B | 2.58B | 2.79B | 2.53B | -2.44B |
| Investing Cash Flow | 0.00 | -3.20B | -3.00B | -207.00M | -1.15B | -1.06B |
| Financing Cash Flow | 0.00 | 643.00M | 74.00M | -2.14B | -1.42B | 3.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | ¥28.20B | 11.47 | ― | 1.94% | 2.71% | 10.31% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥52.25B | 11.30 | ― | 0.52% | -1.79% | 27.43% | |
59 Neutral | ¥26.01B | 28.66 | ― | 3.23% | -0.09% | 17.71% | |
58 Neutral | ¥12.00B | 10.12 | ― | 4.65% | 3.96% | 116.45% | |
55 Neutral | ¥25.02B | 9.35 | ― | 1.93% | 0.59% | -36.05% |